More articles from Review

  • Assessing the risk of surgery in patients with liver disease
    Amitabh Suman, MD and William D. Carey, MD
    Cleveland Clinic Journal of Medicine April 2006, 73 (4) 398-404;

    All liver disease is not the same, and neither is all surgery, but recent studies have defined objective criteria for determining when surgery is safe for patients with liver disease.

  • Update in ARDS management: Recent randomized controlled trials that changed our practice
    J. Fernando Santacruz, MD, Enrique Diaz Guzman Zavala, MD and Alejandro C. Arroliga, MD
    Cleveland Clinic Journal of Medicine March 2006, 73 (3) 217-236;

    Although the death rate remains high in the acute respiratory distress syndrome (ARDS), several advances have been made in the past decade.

  • Buying prescription drugs on the Internet: Promises and pitfalls
    Alan M. Weiss, MD, MBA
    Cleveland Clinic Journal of Medicine March 2006, 73 (3) 282-288;

    Patients can save time and money, but they can also end up with counterfeit or substandard medications.

  • Anemia in chronic kidney disease: Causes, diagnosis, treatment
    Anemia in chronic kidney disease: Causes, diagnosis, treatment
    Saul Nurko, MD
    Cleveland Clinic Journal of Medicine March 2006, 73 (3) 289-297;

    Most patients with chronic kidney disease eventually become anemic and need erythropoiesis-stimulating agents.

  • Diagnosing and managing posttraumatic stress disorder
    Kumar Budur, MD, Tatiana Falcone, MD and Kathleen Franco, MD
    Cleveland Clinic Journal of Medicine February 2006, 73 (2) 121-129;

    PTSD not only affects soldiers, it also occurs in civilians exposed to severe trauma or serious illness. Manifestations commonly include nonspecific physical symptoms, and patients often present to their primary care physician.

  • Multiple sclerosis: Treating symptoms, and other general medical issues
    Myla D. Goldman, MD, Jeffrey A. Cohen, MD, Robert J. Fox, MD and Francois A. Bethoux, MD
    Cleveland Clinic Journal of Medicine February 2006, 73 (2) 177-186;

    Disease-modifying therapies have been a big advance in multiple sclerosis, but many patients still experience a variety of symptoms that reduce quality of life. We have to treat the whole patient.

  • <em>Clostridium difficile</em>-associated disease: New challenges from an established pathogen
    Clostridium difficile-associated disease: New challenges from an established pathogen
    Rebecca H. Sunenshine, MD and L. Clifford McDonald, MD
    Cleveland Clinic Journal of Medicine February 2006, 73 (2) 187-197;

    Clostridium difficile-associated disease (CDAD) is increasing in incidence and severity and may be becoming more difficult to treat. A new strain is causing many outbreaks.

  • Evaluating and managing hypogammaglobulinemia
    Mark E. Rose, MD and David M. Lang, MD
    Cleveland Clinic Journal of Medicine February 2006, 73 (2) 133-144;

    Patients with frequent and recurrent respiratory infections should be tested for immune system abnormalities. This article describes common primary and secondary forms of hypogammaglobulinemia and how to evaluate and manage them.

  • Familial hypercholesterolemia: A challenge of diagnosis and therapy
    Christopher Sibley, MD and Neil J. Stone, MD
    Cleveland Clinic Journal of Medicine January 2006, 73 (1) 57-64;

    Many people have high cholesterol, but a distinct minority have extremely high levels due to genetic defects in lipoprotein metabolism. They need our special attention.

  • Multiple sclerosis: Advances in understanding, diagnosing, and treating the underlying disease
    Robert J. Fox, MD, Francois Bethoux, MD, Myla D. Goldman, MD and Jeffrey A. Cohen, MD
    Cleveland Clinic Journal of Medicine January 2006, 73 (1) 91-102;

    In spite of setbacks, the future holds hope for patients and clinicians struggling against this disease.

Pages